Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2023-12-20 00:00:00 ET · period of report 2023-12-19 · accession 0001127602-23-030187 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-20 | 2023-12-19 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | F - Tax | $6.05 | -14.1K | 1.11M | -1% | -$85.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-19 | F | D | 14,089 | $6.05 | 1,114,770 | D | — | — | (F1) Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person. |